Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

MDS 2020 | Impact of COVID-19 on neurological disorders

Elena Moro • 22 Sep 2020
MDS 2020
Movement Disorders Multiple Sclerosis and Related Disorders

Elena Moro, MD, PhD, CHU Grenoble Alpes, Grenoble, France, discusses whether COVID-19 will impact patients with neurological disorders. Currently, patients with multiple sclerosis (MS) have not shown worse disease progression, however, follow-up of these patients is necessary to fully understand the impact of the virus. This interview was recorded during an online conference call with The Video Journal of Neurology (VJNeurology).

More from Elena Moro

3:24
COVID-19 neurological manifestations: short and long-term
Elena Moro • 22 Sep 2020
3:21
Deep brain stimulation as an effective treatment for Parkinson’s disease, dystonia and tremor
Elena Moro • 22 Sep 2020

Related Videos

3:44
Navigating intra-individual variability for early detection of cognitive decline
Leigh Charvet • 23 Feb 2024
3:26
Acupressure for the management of pain and anxiety in patients with MS
Megan Weigel • 4 Mar 2024
5:42
Mapping the functional interactome in MS lesions to shed light on remyelination failure
Milos Opacic • 5 Mar 2024
5:37
GAIT-HUB: a home-based gait monitoring system for patients with MS
Giuseppina Pilloni • 4 Mar 2024
The content of VJNeurology is intended for healthcare professionals